Utah’s regulatory sandbox allows Doctronic AI chatbot to facilitate prescription refills. During Phase 1, human doctors review all refill orders. Company plans fully automated refills later. Utah medical board opposed; 11 board members called for halt in March 2026 citing medication side effects and drug interactions.
FDA has not authorized any AI chatbot for prescriptions. Doctronic considers its AI part of state-regulated medicine practice. Texas, Wyoming, and Cicero Institute-backed bills expanding similar pilots. Formulary: 192 maintenance medications; no new prescriptions or controlled substances.